Drug trial results and the stock moves that follow

2 resultsFlops (missed / terminated / rejected) Phase 3
Missed endpoint

TNX-103

Phase 3 n=230 Pulmonary Hypertension

Tenax Therapeutics TENX

24h stock move −89.29%

Daily roundups

For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.